Skip to main content

Type 2 Diabetes Clinical Trials (Insulin Naive Therapy)

Diabetes Management Clinical Trials Now Enrolling!

Take Control of Your Blood Sugar!

Explore Type 2 Diabetes Clinical Trials (Insulin Naive Therapy) for Alternate Management Options!

Taking insulin daily might not be everyone’s cup of tea. We are working on a once-weekly long-acting dosage that offers a more convenient alternative to daily insulin. Your participation may help us achieve this.

According to the World Health Organization (WHO), around 442 million people have Type 2 Diabetes. It occurs when the pancreas is unable to produce enough insulin naturally. Without appropriate treatment, blood glucose levels rise and cause damage to the heart, kidneys, and eyes.
Oral antihyperglycemic medications are given initially. Over time, oral medications may not be enough to control blood glucose. Insulin therapy is initiated in insulin-naive patients.
Prime Revival Research Institute is conducting Type 2 Diabetes Clinical Trials to help insulin naive diabetics manage their blood glucose levels.

You may be able to participate if you:

  • Are at least 18 years old
  • Have been diagnosed with Type 2 Diabetes
  • Have taken at least 1 medicine to treat your diabetes for the past 3 months
  • Have not been prescribed insulin before

Your doctor will review additional study criteria with you and see if you qualify. If you qualify and decide to participate in the Type 2 Diabetes Clinical Trials, you will receive all study-related care.

Please provide YOUR contact information only.

*There is no cost to you or your private medical insurance to participate in the Type 2 Diabetes Clinical Trials. You will receive monetary compensation for your time and travel. And all participants receive study-related care from doctors & health care professionals, free of cost.
*If you think you may be eligible to participate in the Type 2 Diabetes Clinical Trials (insulin naive) or would like more information, please enter your information so we can see if you may qualify and can contact you about the study.

Insulin Naive Therapy Type 2 Diabetes Clinical Trials

About the Type 2 Diabetes Clinical Trials (Insulin Naive)

Prime Revival Research Institute is conducting Phase 3, Type 2 Diabetes Clinical Trials (insulin naive) on a once-weekly insulin dosage investigational study drug. An autoinjector will be used for its administration during the initial 16 weeks. After this, you may need to use a prefilled pen. A total of 670 participants will be assigned insulin glargine and the investigational drug.

The aim of the Type 2 Diabetes Clinical Trials (insulin naive) is to provide a more convenient weekly alternative to the daily insulin regimen for those who have not been given insulin before. This study will consist of approximately 33 visits for about 60 weeks (a little over a year). Around half of these visits will be telemedicine and will not require traveling. The type 2 diabetes research study is divided into 3 phases:

  • Screening and a Lead-In Period (3 weeks)
  • Study Treatment Period (52 weeks)
  • Safety Follow-up Period (5 weeks)

Participants will also receive training related to diabetes self-monitoring and management, glucose monitoring, and study requirements. If you want to partake in a similar Type 2 Diabetes Research Study, have a look at our Continuous Glucose Monitoring Study (CGM).

About Type 2 Diabetes

Type 2 Diabetes, also known as “adult-onset diabetes,” is the most common type of diabetes characterized by high blood sugar (glucose) levels. Symptoms typically experienced by Type 2 diabetic individuals are excessive thirst and dry mouth, frequent urination, lethargic feeling, slow healing of wounds, recurrent skin infections, pain, and tingling sensations in the lower extremities followed by upper extremities (possibly diabetic peripheral neuropathy).

Numerous risk factors influence the development of diabetes, the most influential are changes in diet and physical activity associated with rapid urbanization. Other potential risk factors are family history, unhealthy eating, obesity, lack of exercise, age, etc. The anticipated treatment for diabetes management usually involves taking oral medications initially. The most commonly prescribed oral medications are metformin and sulfonylureas. Insulin is either used as an adjunct with oral medications or used individually as the only treatment option when oral medications stop producing results as the disease progress. Over time adopting healthy lifestyle changes such as incorporating regular exercise (swimming, cycling, yoga), avoiding sugar, and replacing saturated fats (cream, cheese) with unsaturated fats (nuts, vegetable oil) in the diet helps better manage diabetes.

Type 2 Diabetes Clinical Trials Insulin Naive Therapy

Not RecruitingSTATUS AND CRITERIA

$ 99

Per Month
  • Age 18 years or above
  • Gender Male or Female
  • Condition Type 2 Diabetes (Insulin Naive)
  • Location Texas
Enroll Now

What to Expect?

If you would like to learn more about our Type 2 Diabetes Clinical Trials (insulin naive), please fill out the form above. One of our research representatives will call you to give you further information about the study. If you qualify for the Type 2 Diabetes Clinical Trials, you will be invited to our study site for screening. After the screenings, if you qualify and decide to participate, you will be asked to sign an informed consent form which includes the criteria and details of the investigational study treatment.

Once signed, you will be asked health-related questions, and several health assessments and tests will be conducted to help determine if you are eligible as a volunteer. You will be assigned to either of the 2 groups in which you will receive insulin glargine using an autoinjector on a once-weekly basis or the investigational study drug.

*Participants will receive free-of-cost investigational treatment. If participants decide to participate in the Type 2 Diabetes Research study, they may also receive study-related care from healthcare professionals.

Frequently Asked Questions (FAQs)

1. For what indications is insulin glargine used?

Insulin glargine, a long-acting synthetic insulin is indicated for Type 1 diabetic individuals both adults and pediatric patients, and in Type 2 diabetic adults depending on their need to improve glycemic control.

2. Do Type 2 diabetics take insulin? At what point does a diabetic need insulin?

Newly diagnosed Type 2 diabetics begin initial treatment with a conservative regime involving diet, exercise, and oral medication. Over time, some people shift to insulin or another injectable medication depending on their blood sugar levels as the oral medications stop being effective. When Type 2 diabetics begin taking insulin, doctors typically advise “basal” insulin/long-acting insulin or intermediate insulin to maintain blood sugar levels throughout the day.

3. What is long-acting insulin?

Long-acting insulin also known as basal insulin provides a gradual, continuous release of insulin hence blood sugar is regulated by insulin both during the day (between meals) and at night.

4. What are the side effects of insulin glargine?

The most common side effects are reactive hypoglycemia, swelling, excess weight gain, hypersensitivity reactions, rash, itching, or allergic reaction and in the area where the medication was injected, the skin thickens or becomes hollow.

5. Where can I find paid clinical trials for Type 2 Diabetes?

If you or a loved one is interested in participating in Type 2 Diabetes Clinical Trials, please fill out the form above. We are conducting Endocrinology Clinical Trials to investigate potential new therapeutic options that may help diabetics manage their diabetes. Participants receive monetary compensation for their time and travel, while insurance is not required to participate.